The Center for Discovery and Innovation is conducting a study involving assessing neutralizing antibody levels of individuals who have received at least one dose of a COVID-19 vaccine.
If you or any of your team members (or others in their circle, e.g. family members) fall into one of the categories described below please contact us to learn more about the study.
You are eligible for this study if you are vaccinated against COVID and fall into one or more of the following categories:
- Have never contracted COVID-19
- Are immunocompromised
- Have previously contracted COVID-19 and fully recovered
- Have previously contracted COVID-19 and continue to suffer from post-COVID symptoms
As part of the study, after informed consent, you will be tested for antibodies using the CDI-developed test (up to 10 ml of blood will be needed). You may opt in to receive your results and/or have any leftover samples used for other COVID, post-COVID or equivalent studies after the evaluations are completed.
If you, or your team members, would like to learn more about the study, please call our Research Coordinator, Elizabeth at (201) 880-3521 or email her at email@example.com with questions or to schedule an appointment to come and get tested.
Location: Jersey Shore University Medical Center, Lavin Lobby, Northwest Pavilion 2 entrance
Dates: Wednesdays, May 11, 16, 18 and 23,
Hours: 9:30 a.m. – 4:30 p.m
*Participants should park in the Harbor Garage to access the Lavin Lobby.